Sensulin is developing a glucose-responsive insulin that mimics a healthy human pancreas, eliminating the need for separate basal and prandial insulin and reducing the need for glucose monitoring. This could offer a substantial improvement in the standard of care for patients with type I and type II diabetes, and give them a chance at a normal life. Sensulin, LLC is dedicated to improving diabetes treatment through innovative drug discovery.